Logo image
Back
Rate of BRCA mutation in patients tested under NCCN genetic testing criteria
Journal article   Peer reviewed

Rate of BRCA mutation in patients tested under NCCN genetic testing criteria

Anna C. Beck, Haimiao Yuan, Junlin Liao, Pamela Imperiale, Krysten Shipley, Lillian M. Erdahl, Sonia L. Sugg, Ronald J. Weigel and Ingrid M. Lizarraga
The American journal of surgery, Vol.219(1), pp.145-149
01/2020
DOI: 10.1016/j.amjsurg.2019.06.012
PMCID: PMC7266680
PMID: 31255259
url
https://www.ncbi.nlm.nih.gov/pmc/articles/7266680View
Open Access

Abstract

BRCA genetic testing is recommended by the National Comprehensive Cancer Network (NCCN) in breast cancer patients who meet specific criteria. Limited data are available on the likelihood of detecting a mutation when these guidelines are followed. A retrospective chart review examined patients with breast cancer who underwent BRCA testing based on NCCN guidelines. Twelve (6.0%) of the 199 patients had a deleterious BRCA mutation. Family history of BRCA mutations (50%, p = 0.019), age ≤45 at diagnosis (9.7%, p = 0.034) and meeting ≥3 NCCN criteria (13.3%, p = 0.03) yielded the highest rates of BRCA mutation. Having a family history of BRCA mutation and age ≤45 were associated with increased rate of BRCA mutation on multivariate analysis (OR 14.3, CI 1.2–166.3; OR 11.6, CI 1.2–108.6). Select NCCN criteria are associated with higher rates of BRCA mutations. Waiting for genetic testing results to guide surgical management may be warranted in this subset of patients. •Following NCCN testing guidelines, 6% of breast cancer patients had a BRCA mutation.•Family history of BRCA mutation and age ≤45 had highest rates of BRCA mutation.•Meeting ≥3 NCCN criteria had a 13% rate of BRCA mutation.•Meeting only 1 NCCN criterion yielded a BRCA mutation rate of 2%.
 BRCA Breast cancer Family history Genetic testing NCCN

Details

Metrics

21 Record Views
17 Times Cited - Web of Science
Logo image